Business

March 7, 2014

Durham drug developer Chimerix reports drop in revenue in 4th quarter

Antiviral drug developer Chimerix reported a drop in revenue in the fourth quarter as a result of reduced reimbursements from a federal contract.

Related content

Comments

Editor's Choice Videos